1. Tarsus Pharmaceuticals Inc. Tarsus Provides 2025 Update: Accelerating the Launch of XDEMVY and Advancing New Programs. (accessed on 29 May 2025).
2. Gade A., Vasile G.F., Hohman M.H., Rubenstein R. StatPearls [Internet] StatPearls Publishing; Treasure Island, FL, USA: 2025. [(accessed on 31 May 2025)].
3. Chen R., Lu J., Dong J., Zhu Y. Intense pulsed light therapy for ocular surface diseases. Lasers Med. Sci. 2024;39:111.
4. Fishman H.A., Periman L.M., Shah A.A. Real-Time Video Microscopy of In Vitro Demodex Death by Intense Pulsed Light. Photobiomodul. Photomed. Laser Surg. 2020;38:472–476.
5. Huo Y., Mo Y., Wu Y., Fang F., Jin X. Therapeutic effect of intense pulsed light with optimal pulse technology on meibomian gland dysfunction with and without ocular Demodex infestation. Ann. Transl. Med. 2021;9:238.
6. Zhang X., Song N., Gong L. Therapeutic Effect of Intense Pulsed Light on Ocular Demodicosis. Curr. Eye Res. 2019;44:250–256.
7. Siegel H., Merz A., Gross N., Bründer M.-C., Böhringer D., Reinhard T., Maier P. BlephEx-treatment for blepharitis: A prospective randomized placebo-controlled trial. BMC Ophthalmol. 2024;24:503.
8. Mohammad-Rabei H., Arabi A., Shahraki T., Rezaee-Alam Z., Baradaran-Rafii A. Role of Blepharoexfoliation in Demodex Blepharitis: A Randomized Comparative Study. Cornea. 2023;42:44–51.
9. Sędzikowska A., Osęka M., Grytner-Zięcina B., Roman B., Jaremko E. Effect of Metronidazol, Mercury Oxide and Essentials Oils on the in vitro survivability of Demodex mites. Okulistyka. 2014;4:64–66.
10. Chudzicka-Strugała I., Gołębiewska I., Brudecki G., Elamin W., Zwoździak B. Demodicosis in Different Age Groups and Alternative Treatment Options: A Review. J. Clin. Med. 2023;12:1649.
11. Pelletier J.S., Capriotti K., Stewart K.S., Capriotti J.A. Demodex Blepharitis Treated with a Novel Dilute Povidone-Iodine and DMSO System: A Case Report. Ophthalmol. Ther. 2017;6:361–366.
12. Heczko J., Schell C., Pansick A., Stein R., Perry H.D. Evaluation of a novel treatment, selenium disulfide, in killing Demodex folliculorum in vitro. Can. J. Ophthalmol. 2023;58:408–412.
13. Liu W., Gong L. Anti-demodectic effects of okra eyelid patch in Demodex blepharitis compared with tea tree oil. Exp. Ther. Med. 2021;21:338.
14. Chudzicka-Strugała I, Gołębiewska I, Brudecki G, Elamin W, Zwoździak B. Demodicosis in Different Age Groups and Alternative Treatment Options—A Review. J Clin Med. 2023;12:1649.
14. Thoemmes MS, Fergus DJ, Urban J, Trautwein M, Dunn RR, Kolokotronis S-O. Ubiquity and Diversity of Human-Associated Demodex Mites. PLoS One. 2014;9(8):e106265
15. Bădescu A, Iancu LS, Statescu L. Demodex: commensal or pathogen? Revista medico-chirurgicala a Societat?ii de Medici si Naturalisti din Ias¸i. 2014;117:189–193.
16. Ayres BD, Donnenfeld E, Farid M, et al. Clinical diagnosis and management of Demodex blepharitis: the Demodex Expert Panel on Treatment and Eyelid Health (DEPTH). Eye. 2023.
17. Coston TO. Demodex folliculorum blepharitis. Trans Am Oph Soc. 1967;65:361–392.
18. Desch C, Nutting WB. Demodex folliculorum (Simon) and D. brevis akbulatova of man: redescription and reevaluation. J Parasitol. 1972;58:169–177.
19. Fatourechi A. Prevalence of Demodex in Association with Ocular Signs and Symptoms: evidence from a Large Population of Male Soldiers Living in Garrison. Annal Milit Health Sci Res. 2022;18.
20. Liu J, Sheha H, Tseng SC. Pathogenic role of Demodex mites in blepharitis. Curr Opin Allerg Clin Imm. 2010;10:505.
21. Lacey N, Kavanagh K, Tseng SC. Under the lash: demodex mites in human diseases. Biochemist. 2009;31:20–24.
22. Basta-Juzbasić A, Subić JS, Ljubojević S. Demodex folliculorum in development of dermatitis rosaceiformis steroidica and rosacea-related diseases. Clin Dermatol. 2002;20(2):135–140.
23. Kamoun B, Fourati M, Feki J, et al. Blepharitis due to Demodex: myth or reality? J Fr Ophtalmol. 1999;22:525–527.
24. Hyun Lee S, Sook Chun Y, Hoon Kim J, Kim ES, Kim JC. The Relationship between Demodex and Ocular Discomfort. Invest Ophthalmol Vis Sci. 2010;51(6):2906–2911.
25. Rufli T, Mumcuoglu Y. ”The hair follicle mites Demodex folliculorum and Demodex brevis: biology and medical importance. A review”. Dermatologica. 1981;162(1):1–11.
26. Stoyanova K, Cvetkova J, Cvetkova T. Diagnosis of skin and eyelid diseases associated with Demodex spp. Scripta Sci Medica. 2023;54(2).
27. Zhao YE, Hu L, Wu LP, Ma JX. A meta-analysis of association between acne vulgaris and Demodex infestation. J Zhejiang Univ Sci B. 2012;13(3):192–202.
28. Bitton E, Aumond S. Demodex and eye disease: a review. Clin Exp Optom. 2021;104(3):285–294.
29. Fromstein S, Harthan J, Patel J, Opitz D. Demodex blepharitis: Clinical perspectives. Clin Optom. 2018;10:57–63.
30. Jing X, Shuling G, Ying L. Environmental scanning electron microscopy observation of the ultrastructure of Demodex. Microsc Res Tech. 2005;68(5):284–289.
31. Paichitrojjana AD. The worst enemies are the ones that used to be friends. Dermatol Rep. 14(3):9339. PMID: 36199896.
32. El-Sherbini MS. Egypt. Acad J Biolog Sci. 2022;14(1):51–61.
33. Litwin D, Chen W, Dzika E, Korycińska J. Human permanent ectoparasites; recent advances on biology and clinical significance of demodex mites: narrative review article. Iran J Parasitol. 2017;12(1):12–21.
34. Ye Q, Yan W, Wang Y, et al. The prevalence of ocular Demodex folliculorum in 2253 young males. Sci Rep. 2022;12:22346.
35. Aylesworth R, Vance JC. Demodex folliculorum and Demodex brevis in cutaneous biopsies. J Am Acad Dermatol. 1982;7(5):583–589.
36. Wesolowska M, Knysz B, Reich A, et al. Clinical research prevalence of demodex spp. in eyelash follicles in different populations. Arch Med Sci. 2014;10:2):319–324.
37. Kubanov A, Yulia G, Grevtseva A. Important aspects of Demodex diagnostics. J of Surg Derm. 2016;1(1):43–51.
38. Rather PA, Hassan I. Human demodex mite: the versatile mite of dermatological importance. Indian J Dermatol. 2014;59(1):60–66.
39. Ivy SP, Mackall CL, Gore L, Gress RE, Hartley AH. Demodicidosis in childhood acute lymphoblastic leukemia; an opportunistic infection occurring with immunosuppression. J Pediatr. 1995;127(5):751–754.
40. Benessahraoui M, Paratte F, Plouvier E, Humbert P, Aubin F. Demodicidosis in a child with xantholeukaemia associated with type 1 neurofibromatosis. Eur J Dermatol. 2003;13(3):311–312.
41. Akilov OE, Mumcuoglu KY. Association between human demodicosis and HLA class I. Clin Exp Dermatol. 2003;28(1):70–73.
42. Nicholls SG, Oakley CL, Tan A, Vote BJ. Demodex species in human ocular disease: new clinicopathological aspects. Int Ophthalmol. 2017;37:303–312.
43. Zhang AC, Muntz A, Wang MTM, Craig JP, Downie LE. Ocular Demodex: a systematic review of the clinical literature. Ophthalmic Physiol Opt. 2020;40:389–432.
44. Kabataş N, Doğan AŞ, Kabataş EU, Acar M, Biçer T, Gürdal C. The effect of Demodex infestation on blepharitis and the ocular symptoms. Eye Contact Lens. 2017;43:135–140.
45. Singalavanija T. Update on Demodex Blepharitis. J Chulabhorn Royal Acad. 2020;2(3):44–52.
46. Tatu AL, Ionescu MA, Cristea VC. Demodex folliculorum associated Bacillus pumilus in lesional areas in rosacea. Indian J Dermatol Venereol Leprol. 2017;83:610–611.
47. Maier T, Sattler E, Braun-Falco M, Ruzicka T, Berking C. High-definition optical coherence tomography for the in vivo detection of demodex mites. Dermatology. 2012;225(3):271–276. PMID: 23257730.
48. Tatu AL, Clatici VG, Nwabudike LC. Rosacea-like demodicosis (but not primary demodicosis) and papulopustular rosacea may be two phenotypes of the same disease – a microbioma, therapeutic and diagnostic tools perspective. J Eur Acad Dermatol Venereol. 2019;33:e46–e47.
49. Luo X, Li J, Chen C, Tseng S, Liang L. Ocular Demodicosis as a Potential Cause of Ocular Surface Inflammation. Cornea. 2017;1(Suppl 1):S9–S14.
50. Rhee MK, Yeu E, Barnett M, et al. Demodex Blepharitis: a Comprehensive Review of the Disease, Current Management, and Emerging Therapies. Eye Contact Lens. 2023;49(8):311–318.
51. Ak Taş Karabay E, Çerman AA. Demodex folliculorum infestations in common facial dermatoses: acne vulgaris, rosacea, seborrheic dermatitis. Anais Brasileiros de Derm. 2020;95(2):187–193.
52. Lungu M, Telehuz A, Voinescu DC, et al. NK/T cell non Hodgkin lymphoma: case report and review of the literature. Exp Ther Med. 2021;21:91.
53. Victoria Elverhaug (2020). Demodex in humans and their clinical implications, [Master’s Thesis, University of South-Eastern Norway].
54. Bobeica C, Niculet E, Tatu AL, et al. Old and new therapeutic strategies in systemic sclerosis (Review). Exp Ther Med. 2022;23(2):134.
55. Buddenkotte J, Steinhoff M. Recent advances in understanding and managing rosacea. F1000Research. 2018;7(F1000 Faculty Rev):1885.
56. Lacey N, Russell-Hallinan A, Zouboulis CC, Powell FC. Demodex mites modulate sebocyte immune reaction: possible role in the pathogenesis of rosacea. Br J Dermatol. 2018;179(2):420–430.
57. Moravej H. ”Association of rosacea with demodicosis”; 2007: 199–203.
58. Chen W, Plewig G. Human demodicosis: revisit and a proposed classification. Br J Dermatol. 2014;170(6):1219–1225.
59. Cribier B. Rosacée: nouveautés pour une meilleure prise en charge [Rosacea: new data for better care]. Ann Dermatol Venereol. 2017;144(8–9):508–517.
60. Ahn CS, Huang WW. Rosacea Pathogenesis. Dermatol Clin. 2018;36(2):81–86.
61. Powell FC. Rosacea and the pilosebaceous follicle. Cutis. 2004;74(3 Suppl):9-12.
62. O’Reilly N, Menezes N, Kavanagh K. Positive correlation between serum immunoreactivity to Demodex associated Bacillus proteins and erythematotelangiectatic rosacea, British. J Dermatol. 2012;167(5):1032–1036.
63. Maher A, Staunton K, Kavanagh K. Analysis of the effect of temperature on protein abundance in Demodex-associated Bacillus. Oleronius Pathog Dis. 2018;76:032.
64. Zhao Y, Guo N, Xun M, et al. Sociodemographic characteristics and risk factor analysis of Demodex infestation. J Zhejiang Univ Sci. 12:998–1007.
65. Millikan LE ”Androgenetic alopecia: The role of inflammation and Demodex”; (2002): 475–476.
66. Helou W, Avitan-Hersh E, Bergman R. ”Demodex folliculitis of the scalp: clinicopathological study of an uncommon entity”. Amer J Dermat. 2016;658–663.
67. Gao YY, Di Pascuale MA, Li W, et al. High prevalence of Demodex in eyelashes with cylindrical dandruff. Invest Ophthalmol Vis Sci. 2005;46:3089–3094.
68. Salem DA, El-Shazly A, Nabih N, El-Bayoumy Y, Saleh S. Evaluation of the efficacy of oral ivermectin in comparison with ivermectin-metronidazole combined therapy in the treatment of ocular and skin lesions of Demodex folliculorum. Int J Infect Dis. 2013;17(5):e343–7.
69. Lacey N, Delaney S, Kavanagh K, Powell F. Mite-related antigens stimulate inflammatory cells in rosacea. British j Dermat. 2007;157:474–481.
70. Randon M, Liang H. El Hamdaoui M, et alIn vivo confocal microscopy as a novel and reliable tool for the diagnosis of Demodex eyelid infestationBritish. J Ophthal. 2015;99:336–341.
71. Forton F, Seys B. Density of Demodex folliculorum in rosacea: a case-control study using standardized skin-surface biopsy. Br J Dermatol. 1993;128:650–659.
72. Jacob S, VanDaele MA, Brown JN. Treatment of Demodex-associated inflammatory skin conditions: A systematic review. Dermatol Ther. 2019;32:e13103.
73. Culp B, Scheinfeld N. Rosacea: a review. P T. 2009;34(1):38–45.
74. Zhao YE, Guo N, Wu LP. The effect of temperature on the viability of Demodex folliculorum and Demodex brevis. Parasitol Res. 2009;105:1623–1628.
75. Gao Y, Di Pascuale M, Li W, et al. In Vitro and In Vivo killing of ocular Demodex by tea tree oil. Br J Ophthalmol. 2005;89:1468–1473.
76. Carson CF, Hammer KA, Riley TV. Melaleuca alternifolia (tea tree) oil: A review of antimicrobial and other medicinal properties. Clin Microbiol Rev. 2006;19:50–62.
77. Tighe S, Gao YY, Tseng SC. Terpinen-4-ol is the Most active ingredient of tea tree oil to kill Demodex mites. Transl Vis Sci Technol. 2013;2:2.
78. Do Socorro SRMS, Mendonca-Filho RR, Bizzo HR, et al. Antileishmanial activity of a linalool-rich essential oil from croton cajucara. Antimicrob Agents Chemother. 2003;47:1895–1901.
79. Zhang X, Song N, Gong L. Therapeutic Effect of Intense Pulsed Light on Ocular Demodicosis. Curr Eye Res. 2019;44(3):250–256.
80. Kabat AG. In vitro demodicidal activity of commercial lid hygiene products. Clin Ophthalmol. 2019;13:1493–1497.
81. Liu W, Gong L. Anti-demodectic effects of okra eyelid patch in Demodex blepharitis compared with tea tree oil. Exp Ther Med. 2021;21(4):338. Epub 2021 Feb 10.
82. Craig JP, Rupenthal ID, Seyfoddin A, et al. Preclinical development of MGO Manuka honey microemulsion for blepharitis management. BMJ Open Ophtl. 2017;1:e000065.
83. Papageorgiou P, Clayton W, Norwood S, et al. Treatment of rosacea with intense pulsed light: significant improvement and long-lasting results. Br J Dermatol. 2008;159:628–632.
84. Tatu AL, Ionescu MA, Clatici VG, Cristea VC. Bacillus cereus strain isolated from Demodex folliculorum in patients with topical steroid-induced rosaceiform facial dermatitis. An Bras Dermatol. 2016;91(5):676–678.
85. Raszeja‐Kotelba B., Jenerowicz D., Izdebska J. N., Bowszyc‐Dmochowska M., Tomczak M., and Dembińska M., “Some Aspects of the Skin Infestation by Demodex Folliculorum,” Wiadomosci Parazytologiczne 50, no. 1 (2004): 41–54.
86. Lacey N., Kavanagh K., and Tseng S. C. G., Under the Lash: Demodex Mites in Human Diseases,” Biochemist 31, no. 4 (2009): 20–24.
87. Wesolowska M., Knysz B., Reich A., et al., Prevalence of Demodex Spp. in Eyelash Follicles in Different Populations, Archives of Medical Science 2, No. 2 (2014): 319–324.
88. Pence K. B., Demırci G., and Sakul B. U., Persistence of Demodex folliculorum mites in the eyelash follicles of human cadavers. Asian Journal of Research and Reports in Ophthalmology 6, No. 1 (2023): 92–97.
89. Foley R., Kelly P., Gatault S., and Powell F., Demodex: A Skin Resident in Man and His Best Friend. Journal of the European Academy of Dermatology and Venereology 35, No.1 (2021): 62-72.
90. Aktaş Karabay E. and Aksu Çerman A., “ Demodex folliculorum infestations in Common Facial Dermatoses: Acne Vulgaris, Rosacea, Seborrheic Dermatitis,” Anais Brasileiros de Dermatologia 95, no. 2 (2020): 187-193.
91. Chudzicka‐Strugała I., Gołębiewska I., Brudecki G., Elamin W., and Zwoździak B.Demodicosis in Different Age Groups and Alternative Treatment Options: A review. Journal of Clinical Medicine 12, No.4 (2023): 1649.
92. Fromstein S. R., Harthan J. S., Patel J., and Opitz D. L.Demodex blepharitis: Clinical Perspectives. Clinical Optometry 10 (2018): 57–63.
93. Hsu C.‐K., Hsu M. M.‐L., and Lee J. Y.‐Y., Demodicosis: A Clinicopathological Study,” Journal of the American Academy of Dermatology 60, no. 3 (2009): 453–462.
94. Kemal M., Sümer Z., Toker M. I., Erdoğan H., Topalkara A., and Akbulut M. The Prevalence of Demodex folliculorum in Blepharitis Patients and the Normal Population. Ophthalmic Epidemiology 12, no. 4 (2005): 287-290.
95. Elston D. M., Demodex Mites: Facts and Controversies. Clinics in Dermatology 28, no. 5 (2010): 502–504.
96. Kargadouri A., Beleri S., and Patsoula E., “Data on Demodex Ectoparasite Infestation in Patients Attending an Outpatient Clinic in Greece,” Parasitologia 4, No.2 (2024): 129-136.
97. Rychlik K., Sternicka J., Zabłotna M., Nowicki R. J., Bieniaszewski L., and Purzycka‐Bohdan D., The Prevalence of Demodex Spp. Infestation in Dermatological Patients in Northern Poland,” Life 14, no. 9 (2024): 1196.
98. Królik S., Muth A., Polańska A., Żaba R., Adamski Z., and Jenerowicz D., “Demodicosis in Humans as a Current Problem in Dermatology and Ophthalmology,” Journal of Face Aesthetics 3, no. 2 (2020): 108–121.
99. El‐Sherbini M. S., Bocktor N. Z., and Hamed A. M., “Re‐Evaluating the Role of Demodex Mite in Skin Bio‐Balance and,” Egyptian Academic Journal of Biological Sciences, E. Medical Entomology & Parasitology 14, no. 1 (2022): 51–62.
100. J. Kowalczyk M., Derebecka N., Żaba R., et al., “Novel Demodex Detection Method Involving Non‐Invasive Sebum Collection and Next‐Generation Sequencing,” Advances in Dermatology and Allergology 39, no. 2 (2022): 321–326.
101. Pappas A., Fantasia J., and Chen T., Age and Ethnic Variations in Sebaceous Lipids. Dermato‐Endocrinology 5, no. 2 (2013): 319–324.
102. Shaku M., Kuroda H., Nozawa S., and Morita K., “The Quantity and Variation of Human Surface Lipids,” Journal of Society of Cosmetic Chemists of Japan 12, no. 2 (1978): 29–35.
103. Muñoz‐Guzmán M. A. and Alba‐Hurtado F., Progesterone and Prolactin: Hormones Important for the Reactivation of Toxocara canis Larvae in Bitches. Advances in Neuroimmune Biology 7, No. 1 (2018): 67–78.
104. Chávez‐Güitrón L. E., Morales‐Montor J., Muñoz‐Guzmán M. A., et al., “The in Vitro Effect of Prolactin on the Growth, Motility and Expression of Prolactin Receptors in Larvae of Toxocara canis. Veterinary Parasitology 224 (2016): 33–38.
105. Chávez‐Güitrón L. E., Morales‐Montor J., Nava‐Castro K. E., et al., “Progesterone in Vitro Increases Growth, Motility and Progesterone Receptor Expression in Third Stage Larvae of Toxocara canis ,” Experimental Parasitology 198 (2019): 1–6.
106. Wójcik A., Kubiak M., and Rotsztejn H., “Influence of Azelaic and Mandelic Acid Peels on Sebum Secretion in Ageing Women,” Advances in Dermatology and Allergology 3, no. 3 (2013): 140–145.
107. Sędzikowska A., Osęka M., and Skopiński P., “The Impact of Age, Sex, Blepharitis, Rosacea and Rheumatoid Arthritis on Demodex Mite Infection,” Archives of Medical Science 14, No. 2 (2018): 353–356.
108. Wei F., Li L., Kong Y., et al., “Evidence for the Clinical Association Between Demodex and Rosacea: A Review,” Dermatology 240, No.1 (2024): 95-102.
109. Chioveanu F., Niculet E., Torlac C., Busila C., and Tatu A., Beyond the Surface: Understanding Demodex and Its Link to Blepharitis and Facial Dermatoses. Clinical Ophthalmology 18 (2024): 1801-1810, 10.2147/opth.S440199.
TS.BS. Huỳnh Hồng Quang
Viện Sốt rét-KST-CT Quy Nhơn